FDA, EUA Authorized Rapid Antigen CLIA-Waived Test Kits
As an intended point-of-care (POC) designated test with a 10 minute processing time, Rapid Antigen Detection allows effective screening of COVID-19 infection on a large scale.
- For health care providers with a CLIA certificate of waiver, we offer an FDA EUA authorized rapid antigen test.
- Lateral flow assay
- Rapid results in 10 minutes
- Nasopharyngeal swab specimen collection
- Intended at POC setting (i.e., in patient care settings) by medical professionals operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation
- Detect SARS-CoV-2 nucleocapsid protein antigen
- Identify acute infection in symptomatic patients with 88.4% sensitivity and 100% specificity
- Designated as a CLIA waived tests
- Made in America
- Not intended for home use
- $25 per Unit (20 Units per Package)
- Please allow 2-3 Business Days for Shipping